Domestic pharmaceutical companies are focusing on developing generic drug of Celebrex which records an annual of more than 50 billion won

Domestic pharmaceutical companies are focusing on developing generic drug of Celebrex which records an annual of more than 50 billion won. On June 5, according to the Ministry of Food and Drug Safety, 10 companies are in the process of developing generic drug of Celebrex. Also, 20 companies have already completed development of generic drug and received approval. However, generics cannot be rel...